ViCentra B.V.

ViCentra B.V. is a medical technology company headquartered in Utrecht, in the Netherlands, that develops and manufactures the Kaleido insulin patch pump. The company's stated aim is to improve life with diabetes through empathetic innovation, simplicity, and design excellence. Kaleido is positioned as the world's smallest and lightest insulin patch pump: a flexible, discreet, wearable insulin delivery system built to the form and function of a lifestyle product, using premium materials and customisable aluminium shells in ten colour options.

ViCentra's work spans medical device development, wearable insulin delivery, insulin pump hardware, industrial design, human-centred design and manufacturing. The design brief extends beyond clinical performance to self-expression, quality of life, freedom and confidence for people using the device daily.

The product is currently sold in three markets - Germany, the Netherlands and France - with the company preparing for market entry in the United States and expanding across Europe. Investors in ViCentra include Innovation Industries, Partners in Equity, Invest-NL, EQT Life Sciences, ROM Utrecht Region, Venturing Tech, Health Innovations and INKEF.